Rapid Reviews with Health-Technology Assessments in Reimbursement Systems – an Examination of Ireland as a Case Study:

Global & Regional Health Technology Assessment

AileenMurphy¹ 

关键词: Health technology assessment;    Irel;    Rapid reviews;    Reimbursement;   

DOI  :  10.5301/grhta.5000250

学科分类：医学（综合）

来源: Sage Journals

【 摘 要 】

IntroductionAs the pace of health-technology innovations increases, greater pressure is placed on health-technology assessment (HTA) agencies to review and make recommendations promptly. One response to this pressure is the use of rapid reviews (RRs). Since 2009 all new drugs in Ireland are first subject to a RR. The RR process refers costly drugs and those with uncertainty surrounding their cost effectiveness for a full HTA. The objective of this study is to explore differences between drugs that were subject to RR only and a full HTA, compare the number of HTAs in Ireland to those in other jurisdictions and examine what factors determine the outcome of an RR, i.e. if a full HTA is recommended or not.MethodsData on drug evaluations from 2009 to July 2015 were extracted from the NCPE, SMC and NICE websites to support the univariate and comparative analysis. A logit regression was employed to determine the factors influencing the outcome of the RR, i.e. the recommendation for a full HTA. Also, propensity s...

【 授权许可】

CC BY